Feifeng Song

Dr. Feifeng Song

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
YHYongjun Hu
Yongjun Hu
FSFeifeng Song
Feifeng Song
Hui-Di JiangHui-Di Jiang
Hui-Di Jiang
GNGabriel Nuñez
Gabriel Nuñez
DSDavid Smith
David Smith
There is increasing evidence that proton-coupled oligopeptide transporters (POTs) can transport bacterially derived chemotactic peptides and therefore reside at the critical interface of innate immune responses and regulation. However, there is substantial contention regarding how these bacterial peptides access the cytosol to exert their effects and which POTs are involved in facilitating this process. Thus, the current study proposed to determine the (sub)cellular expression and functional activity of POTs in macrophages derived from mouse bone marrow and to evaluate the effect of specific POT deletion on the production of inflammatory cytokines in wild-type, Pept2 knockout and Pht1 knockout mice. We found that PEPT2 and PHT1 were highly expressed and functionally active in mouse macrophages, but PEPT1 was absent. The fluorescent imaging of muramyl dipeptide–rhodamine clearly demonstrated that PEPT2 was expressed on the plasma membrane of macrophages, whereas PHT1 was expressed on endosomal membranes. Moreover, both transporters could significantly influence the effect of bacterially derived peptide ligands on cytokine stimulation, as shown by the reduced responses in Pept2 knockout and Pht1 knockout mice as compared with wild-type animals. Taken as a whole, our results point to PEPT2 (at plasma membranes) and PHT1 (at endosomal membranes) working in concert to optimize the uptake of bacterial ligands into the cytosol of macrophages, thereby enhancing the production of proinflammatory cytokines. This new paradigm offers significant insight into potential drug development strategies along with transporter-targeted therapies for endocrine, inflammatory, and autoimmune diseases.

6 November 2019 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
FSFeifeng Song
Feifeng Song
ZXZixue Xuan
Zixue Xuan
XYXiuli Yang
Xiuli Yang
XYXiaolan Ye
Xiaolan Ye
ZPZongfu Pan
Zongfu Pan
QFQingxia Fang
Qingxia Fang

1 October 2021 in Journal of Zhejiang University (Medical Sciences)
Verified
Journal Article
Closed access
FSFeifeng Song
Feifeng Song
YZYiwen Zhang
Yiwen Zhang
ZPZongfu Pan
Zongfu Pan
QZQi Zhang
Qi Zhang
XLXixuan Lu
Xixuan Lu
PHPing Huang
Ping Huang
探讨白藜芦醇抑制肝癌细胞转移的分子机制。 利用CCK-8法检测白藜芦醇对肝癌细胞HepG2和Huh7存活率的影响,筛选后续实验适合的浓度;实时定量RT-PCR检测肝癌组织和肝癌细胞中miR-186-5p的表达;细胞划痕实验、Transwell小室实验和蛋白质印迹法分别检测白藜芦醇或miR-186-5p表达变化对肝癌细胞HepG2和Huh7迁移、侵袭和上皮-间质转化相关蛋白表达的影响。 6.25 μmol/L白藜芦醇对肝癌细胞HepG2和Huh7的存活率无显著影响,遂后续实验中白藜芦醇的浓度选择6.25 μmol/L。实验结果显示, 白藜芦醇可以抑制肝癌细胞的迁移和侵袭,并增加上皮钙黏素表达,降低波形蛋白和Twist1表达(均 P<0.05)。与癌旁组织和正常肝细胞相比,肝癌组织和肝癌细胞中miR-186-5p表达均下调(均 P<0.05)。白藜芦醇能诱导肝癌细胞中miR-186-5p的表达(均 P<0.01)。上调miR-186-5p表达可显著抑制肝癌细胞的迁移、侵袭和上皮-间质转化(均 P<0.05),而敲低miR-186-5p表达能阻断白藜芦醇对肝癌细胞迁移、侵袭和上皮-间质转化的抑制作用。 白藜芦醇能体外抑制肝癌转移,其机制可能与上调miR-186-5p表达有关。

19 April 2024 in Advanced Science
Verified
Journal Article
Open access
FSFeifeng Song
Feifeng Song
ZZZhentao Zhang
Zhentao Zhang
WLWeifeng Liu
Weifeng Liu
TXTong Xu
Tong Xu
XHXiaoping Hu
Xiaoping Hu
PHPing Huang
Ping Huang
Cancer metastasis is the leading cause of mortality in patients with hepatocellular carcinoma (HCC). To meet the rapid malignant growth and transformation, tumor cells dramatically increase the consumption of nutrients, such as amino acids. Peptide transporter 1 (PEPT1), a key transporter for small peptides, has been found to be an effective and energy‐saving intracellular source of amino acids that are required for the growth of tumor cells. Here, the role of PEPT1 in HCC metastasis and its underlying mechanisms is explored. PEPT1 is upregulated in HCC cells and tissues, and high PEPT1 expression is associated with poor prognosis in patients with HCC. PEPT1 overexpression dramatically promoted HCC cell migration, invasion, and lung metastasis, whereas its knockdown abolished these effects both in vitro and in vivo. Mechanistic analysis revealed that high PEPT1 expression increased cellular dipeptides in HCC cells that are responsible for activating the MAP4K4/G3BP2 signaling pathway, ultimately facilitating the phosphorylation of G3BP2 at Thr227 and enhancing HCC metastasis. Taken together, these findings suggest that PEPT1 acts as an oncogene in promoting HCC metastasis through dipeptide‐induced MAP4K4/G3BP2 signaling and that the PEPT1/MAP4K4/G3BP2 axis can serve as a promising therapeutic target for metastatic HCC.

17 August 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
TXTong Xu
Tong Xu
WZWanli Zhang
Wanli Zhang
YZYi-Wen Zhang
Yi-Wen Zhang
FSFeifeng Song
Feifeng Song
PHPing Huang
Ping Huang
Anaplastic thyroid cancer (ATC), an aggressive malignancy with virtually 100% disease‐specific mortality, has long posed a formidable challenge in oncology due to its resistance to conventional treatments and the severe side effects associated with current regimens such as doxorubicin chemotherapy. Consequently, there was urgent need to identify novel candidate compounds that could provide innovative therapeutic strategies for ATC. Ophiopogonin D′ (OPD'), a triterpenoid saponin extracted, yet its roles in ATC has not been reported. Our data demonstrated that OPD' potently inhibited proliferation and metastasis of ATC cells, promoting cell cycle arrest and apoptosis. Remarkably, OPD' impeded growth and metastasis of ATC in vitro and in vivo, displaying an encouraging safety profile. Regulator of G‐protein signalling 4 (RGS4) expression was significantly up‐regulated in ATC compared to normal tissues, and this upregulation was suppressed by OPD' treatment. Mechanistically, we elucidated that the transcription factor JUN bound to the RGS4 promoter, driving its transactivation. However, OPD' interacted with JUN, attenuating its transcriptional activity and thereby disrupting RGS4 overexpression. In summary, our research revealed that OPD' bound with JUN, which in turn resulted in the suppression of transcriptional activation of RGS4, thereby eliciting cell cycle arrest and apoptosis in ATC cells. These findings could offer promise in the development of high‐quality candidate compounds for treatment in ATC.

2 April 2025 in The FASEB Journal
Verified
Journal Article
Closed access
TXTong Xu
Tong Xu
WZWanli Zhang
Wanli Zhang
SGShaobo Gong
Shaobo Gong
BJBo Jiang
Bo Jiang
ZFZhiyi Fu
Zhiyi Fu
PHPing Huang
Ping Huang